2024年中国合同研究组织（CRO）行业概览：降本增效核心驱动，一站式发展成大势所趋（摘要版）

Investment Rating - The report indicates a positive investment outlook for the China Contract Research Organization (CRO) industry, highlighting a robust growth trajectory and increasing demand for CRO services [3][29]. Core Insights - The CRO industry in China has experienced rapid growth, with the market size increasing from $5.8 billion in 2018 to $11.6 billion in 2022, reflecting a compound annual growth rate (CAGR) of 18.9%. Projections suggest the market will expand from $14 billion in 2023 to $27.8 billion by 2027, with a CAGR of 18.7% [3][29]. - The industry is driven by increasing pharmaceutical R&D investments, with the number of new drug IND applications rising from 1,011 in 2018 to 2,300 in 2022, a CAGR of 22.8% [5][31]. - The report emphasizes the advantages of CROs in drug development, including specialized talent, quality control, economies of scale, and cost management, which are essential for pharmaceutical companies facing high R&D costs and long timelines [4][10][11]. Summary by Sections Industry Overview - The CRO industry provides specialized services for drug discovery, preclinical research, and clinical trials, aiming to shorten development cycles, control costs, and reduce risks [3][8]. - The industry is characterized by high certainty due to the systematic and high-stakes nature of drug development, which necessitates the expertise and efficiency that CROs offer [4][11]. Market Size - The market size of the CRO industry in China is projected to grow significantly, driven by increased R&D spending and the emergence of new therapies such as ADCs and cell gene therapies [27][29]. - The report outlines a clear trend towards a "one-stop" service model, where companies expand their service offerings across various stages of drug development [29][30]. Competitive Landscape - The CRO market in China is fragmented with low concentration, featuring a diverse range of players. Leading companies are adopting full-chain layouts and internationalization strategies [39][41]. - The report identifies key players in the industry, including WuXi AppTec, Tigermed, and others, highlighting their unique strengths and market positions [44][48].